North America Veterinary Care Market

North America Veterinary Care Market Research Report Information By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, and Poultry), By Treatment Type (No Medicalization, Basic Medicalization, and Veterinary Care)–and North America Market Forecast Till 2035
ID: MRFR/HC/16219-HCR 128 Pages Rahul Gotadki Last Updated: October 24, 2026
North America Veterinary Care Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.41%
2024 Market Size$ 12.12 Billion
2025 Market Size$ 12.58 Billion
2035 Market Size$ 17.54 Billion
Key Players
Mars Petcare
Zoetis
Boehringer Ingelheim
Elanco Animal Health
Merck Animal Health
VCA Inc.
Opportunities
  • Rising Pet Ownership
  • Regulatory Support and Standards
  • Increased Focus on Preventive Care

North America Veterinary Care Market Summary

As per analysis, the North America Veterinary Care Market is projected to grow from USD 12.58 Billion in 2025 to USD 17.54 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.41% during the forecast period (2025 - 2035).

Key Market Trends & Highlights

The North America Veterinary Care Market is experiencing robust growth driven by evolving consumer attitudes and technological innovations.

  • The US remains the largest market for veterinary care, reflecting a strong commitment to pet health and wellness.
  • Canada is emerging as the fastest-growing region, indicating a rising trend in pet ownership and care services.
  • Preventive care dominates the market, while emergency care is rapidly gaining traction among pet owners.
  • Rising pet ownership and advancements in veterinary technology are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 12.12 (USD Billion)
2035 Market Size 17.54 (USD Billion)
CAGR (2025 - 2035) 3.41%

Major Players

Mars Petcare (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Merck Animal Health (US), VCA Inc. (US), PetSmart (US), Nestle Purina PetCare (US), Idexx Laboratories (US)

North America Veterinary Care Market Drivers

Rising Pet Ownership

The North America Veterinary Care Market is experiencing a notable increase in pet ownership, which appears to be a significant driver of market growth. According to recent statistics, approximately 67% of U.S. households own a pet, translating to around 85 million families. This trend is likely to continue, as more individuals view pets as integral family members, thereby increasing the demand for veterinary services.
 
The growing number of pets necessitates regular health check-ups, vaccinations, and emergency care, which in turn fuels the veterinary care market. Furthermore, the rise in pet ownership is accompanied by a shift towards premium pet care products and services, indicating a willingness among pet owners to invest in their pets' health and well-being. This evolving landscape suggests a robust future for the North America Veterinary Care Market.

Regulatory Support and Standards

The North America Veterinary Care Market benefits from a robust regulatory framework that supports animal health and welfare. Government agencies, such as the U.S. Department of Agriculture and the Food and Drug Administration, play a crucial role in establishing standards for veterinary practices and animal care. These regulations ensure that veterinary services meet high-quality standards, fostering trust among pet owners.
 
Additionally, initiatives aimed at improving animal welfare and public health are likely to drive demand for veterinary services. For example, programs promoting spaying and neutering, as well as vaccination campaigns, contribute to the overall health of the pet population. As regulatory support continues to evolve, it is expected to positively impact the North America Veterinary Care Market, encouraging responsible pet ownership and enhancing service delivery.

Increased Focus on Preventive Care

The North America Veterinary Care Market is witnessing a paradigm shift towards preventive care, driven by a growing awareness of pet health among owners. Pet owners are increasingly recognizing the importance of regular veterinary visits for vaccinations, dental care, and wellness exams. This trend is reflected in the rising expenditure on preventive services, which is projected to account for a substantial portion of the overall veterinary care spending.
 
In fact, data indicates that preventive care services could represent nearly 40% of total veterinary expenditures in the near future. This shift not only enhances the health and longevity of pets but also contributes to the financial stability of veterinary practices. As preventive care becomes a priority, the North America Veterinary Care Market is likely to experience sustained growth.

Advancements in Veterinary Technology

Technological innovations are transforming the North America Veterinary Care Market, enhancing the quality and efficiency of veterinary services. The integration of telemedicine, advanced diagnostic tools, and electronic health records is becoming increasingly prevalent. For instance, the use of telehealth services allows veterinarians to consult with pet owners remotely, improving access to care.
 
Moreover, the market for veterinary diagnostic equipment is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 8% in the coming years. These advancements not only streamline operations but also improve patient outcomes, as timely and accurate diagnoses lead to better treatment plans. As technology continues to evolve, it is likely to play a pivotal role in shaping the future of the North America Veterinary Care Market.

Growing Demand for Specialized Veterinary Services

The North America Veterinary Care Market is increasingly characterized by a demand for specialized veterinary services, reflecting the evolving needs of pet owners. As pets are viewed more as family members, owners are seeking advanced care options, including specialty services such as oncology, cardiology, and dermatology. This trend is supported by the establishment of veterinary specialty hospitals and referral practices, which are becoming more common across the region.
 
Market data suggests that the specialty veterinary services segment is expected to grow at a compound annual growth rate of over 10% in the coming years. This growth is indicative of pet owners' willingness to invest in specialized care, thereby driving the overall market. As the demand for specialized services continues to rise, the North America Veterinary Care Market is poised for significant expansion.

Market Segment Insights

By Service Type: Preventive Care (Largest) vs. Emergency Care (Fastest-Growing)

The North America Veterinary Care Market showcases a diverse array of service types, with Preventive Care currently holding the largest market share. This segment focuses on wellness and routine check-ups, significantly influencing pet health and owner decisions. Following this, Emergency Care is rapidly gaining traction among service types, reflecting increasing pet ownership and the rising demand for immediate medical attention during health crises.

Preventive Care (Dominant) vs. Emergency Care (Emerging)

Preventive Care is characterized by routine veterinary visits and vaccinations aimed at maintaining optimal pet health. This segment plays a crucial role in early disease detection and health maintenance, fostering a close relationship between pet owners and veterinary professionals. In contrast, Emergency Care is marked by the need for rapid intervention, often during critical moments. The rising trend in pet ownership and the growing willingness of owners to seek immediate care for their pets drive this segment's growth. The advent of advanced veterinary surgical techniques and around-the-clock emergency facilities are key factors contributing to its emergence and increasing demand.

By Animal Type: Companion Animals (Largest) vs. Livestock (Fastest-Growing)

In the North America Veterinary Care Market, the segment of Companion Animals holds the largest share. This dominance reflects the growing trend of pet ownership across the region, with families increasingly viewing pets as integral members of the household. Conversely, the Livestock segment is emerging as the fastest-growing area, driven by heightened awareness of animal health in agricultural practices and an increasing focus on food safety standards.

Companion Animals (Dominant) vs. Livestock (Emerging)

The Companion Animals segment remains the dominant force in the North America Veterinary Care Market, fueled by pet humanization trends and rising disposable incomes, which have led to increased spending on pet healthcare. Consumers prioritize preventative care, wellness services, and innovative treatments for their pets. On the other hand, the Livestock segment is emerging due to the growing emphasis on sustainable farming practices and advancements in veterinary technologies tailored for large animals. Livestock care is characterized by a focus on preventive health measures, vaccination programs, and herd health management to maximize productivity and animal welfare.

By Product Type: Pharmaceuticals (Largest) vs. Vaccines (Fastest-Growing)

In the North America Veterinary Care Market, the 'Product Type' segment showcases a diverse distribution among its categories. Pharmaceuticals hold the largest share, reflecting their critical role in treating animal health issues. Vaccines, while constituting a smaller market share, are rapidly gaining traction due to increased awareness of disease prevention among pet owners, leading to their designation as the fastest-growing category. Medical devices, nutritional products, and pet food also contribute significantly, with each playing a unique role in the overall market landscape. The growth in this segment is primarily driven by advancements in veterinary technology and a rising emphasis on preventive care. The adoption of innovative pharmaceuticals and vaccines is propelled by the increasing incidences of zoonotic diseases and rising companion animal populations. Furthermore, the nutritional products category is witnessing a surge, aligning with the trends towards holistic pet care, while pet food segments are evolving to meet changing consumer preferences for premium and specialized diets.

Pharmaceuticals (Dominant) vs. Vaccines (Emerging)

Pharmaceuticals represent the dominant force within the North America Veterinary Care Market, characterized by a vast array of medications used for both therapeutic and preventive purposes. This segment is well-established, with a diverse range of anti-infectives, anti-inflammatories, and pain management products. Its strong market presence is supported by continuous research and development, aiming to enhance animal welfare and support veterinary practices. On the other hand, vaccines are emerging as a critical segment, driven by increasing consumer awareness and the demand for preventative healthcare solutions. The shift toward proactive health management in pets is fostering innovation in vaccine development, making this category not only fast-growing but also essential for ensuring the overall health of companion animals.

By End User: Veterinary Clinics (Largest) vs. Animal Hospitals (Fastest-Growing)

In the North America Veterinary Care Market, Veterinary Clinics represent the largest segment in terms of market share. Following closely are Animal Hospitals, which have rapidly been gaining traction among pet owners and animal caretakers. Research Institutions, Pet Owners, and Government Agencies also play critical roles, with their shares reflecting various aspects of veterinary care such as research, pet health management, and regulatory services. Collectively, these segments underscore the diverse ecosystem that characterizes veterinary care in North America.

Veterinary Clinics (Dominant) vs. Animal Hospitals (Emerging)

Veterinary Clinics are a dominant force in the North America Veterinary Care Market, primarily due to their extensive reach and the trust they have built within communities. They offer a broad range of services including preventive care, diagnostics, and routine treatments. Alternatively, Animal Hospitals are emerging as a key player, propelled by increased pet ownership and a growing focus on specialized care. Unlike general clinics, these hospitals often provide advanced medical services such as surgery, emergency care, and specialty consultations. This shift towards comprehensive care has made Animal Hospitals a rapidly growing sector, capturing the interest of pet owners who seek more robust health management solutions for their animals.

Get more detailed insights about North America Veterinary Care Market

Regional Insights

US : Robust Growth and Innovation

The US veterinary care market holds a commanding share of 10.0% in North America, driven by increasing pet ownership and a growing focus on preventive care. Key growth drivers include advancements in veterinary technology, rising disposable incomes, and a heightened awareness of pet health. Regulatory support from agencies like the FDA ensures safety and efficacy in veterinary products, while infrastructure improvements in urban areas facilitate better access to veterinary services.

Canada : Steady Growth Amid Challenges

Canada's veterinary care market, with a share of 2.12%, is experiencing steady growth, fueled by increasing pet adoption rates and a shift towards holistic pet care. Demand trends indicate a rise in specialty services and telemedicine, reflecting changing consumer preferences. Government initiatives aimed at improving animal health standards and welfare are also pivotal in shaping the market landscape, although challenges such as regulatory hurdles persist.

North America Veterinary Care Market Regional Image

Key Players and Competitive Insights

The Veterinary Care Market in North America is characterized by a dynamic competitive landscape, driven by increasing pet ownership, rising awareness of animal health, and advancements in veterinary technology. Key players such as Mars Petcare (US), Zoetis (US), and Elanco Animal Health (US) are strategically positioned to leverage these growth drivers. Mars Petcare (US) focuses on innovation in pet nutrition and health solutions, while Zoetis (US) emphasizes research and development in pharmaceuticals and diagnostics. Elanco Animal Health (US) is actively pursuing partnerships to enhance its product offerings, collectively shaping a competitive environment that prioritizes innovation and customer-centric solutions.

The market structure appears moderately fragmented, with a mix of large corporations and smaller specialized firms. Key players are employing various business tactics, such as localizing manufacturing and optimizing supply chains, to enhance operational efficiency. This collective influence of major companies fosters a competitive atmosphere where agility and responsiveness to market demands are crucial for success.

In December 2025, Zoetis (US) announced a strategic partnership with a leading technology firm to develop AI-driven diagnostic tools for veterinary practices. This move is significant as it positions Zoetis (US) at the forefront of technological innovation, potentially improving diagnostic accuracy and streamlining veterinary workflows. The integration of AI into veterinary care could enhance service delivery and patient outcomes, reflecting a broader trend towards digital transformation in the industry.

In November 2025, Elanco Animal Health (US) launched a new line of sustainable pet care products aimed at reducing environmental impact. This initiative aligns with growing consumer demand for eco-friendly solutions and demonstrates Elanco's commitment to sustainability. By prioritizing environmentally responsible practices, Elanco (US) not only differentiates itself in a competitive market but also appeals to a conscientious consumer base increasingly concerned about sustainability.

In October 2025, Mars Petcare (US) expanded its veterinary clinic network through the acquisition of several independent practices across the Midwest. This strategic expansion enhances Mars Petcare's service capabilities and market reach, allowing for a more integrated approach to pet health. Such acquisitions are indicative of a trend where larger players seek to consolidate their presence in local markets, thereby increasing their competitive edge.

As of January 2026, current trends in the Veterinary Care Market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of agility and responsiveness in meeting the evolving needs of pet owners and veterinary professionals.

Key Companies in the North America Veterinary Care Market include

Recent Industry Developments

In September 2026, Merck Animal Health announced the publication of two peer-reviewed clinical studies on gilvetmab in the Journal of Veterinary Internal Medicine and the Journal of the American Veterinary Medical Association, demonstrating significant clinical benefit in dogs with melanoma or mast cell tumors. This matters because gilvetmab is the first caninized immune checkpoint inhibitor for canine oncology, offering veterinary oncologists an evidence-based immunotherapeutic option for difficult-to-treat cancers. (Source: merck-animal-health.com)

In September 2026, IDEXX Laboratories acquired CoVetAI Inc., a provider of AI-native ambient listening and clinical workflow software for veterinary practices, to integrate into its connected diagnostic and software ecosystem. This matters because it strengthens IDEXX's AI-driven workflow capabilities, helping veterinary teams reduce documentation burden and improve diagnostic utilization across the patient care journey. (Source: ir.idexx.com)

In July 2026, Zoetis launched Portela (relfovetmab) in Canada and the European Union, the first long-acting anti-NGF monoclonal antibody therapy for cats designed to alleviate osteoarthritis pain for up to three months with a single injection. This matters because feline osteoarthritis is significantly underdiagnosed, and a longer-acting injectable option addresses a critical unmet need for sustained pain management and improved treatment compliance. (Source: news.zoetis.com)

   

Future Outlook

North America Veterinary Care Market Future Outlook

The North America Veterinary Care Market is projected to grow at a 3.41% CAGR from 2025 to 2035, driven by increasing pet ownership, advancements in veterinary technology, and rising consumer spending on pet health.

New opportunities lie in:

  • Telemedicine platforms for remote veterinary consultations. Subscription-based pet wellness plans for preventive care. Advanced diagnostic tools for early disease detection in pets.

By 2035, the market is expected to be robust, reflecting sustained growth and innovation.

Market Segmentation

North America Veterinary Care Market End User Outlook

  • Veterinary Clinics
  • Animal Hospitals
  • Research Institutions
  • Pet Owners
  • Government Agencies

North America Veterinary Care Market Animal Type Outlook

  • Companion Animals
  • Livestock
  • Exotic Animals
  • Equine
  • Aquatic Animals

North America Veterinary Care Market Product Type Outlook

  • Pharmaceuticals
  • Vaccines
  • Medical Devices
  • Nutritional Products
  • Pet Food

North America Veterinary Care Market Service Type Outlook

  • Preventive Care
  • Surgical Services
  • Emergency Care
  • Dental Care
  • Diagnostic Services

Report Scope

MARKET SIZE 2024 12.12(USD Billion)
MARKET SIZE 2025 12.58(USD Billion)
MARKET SIZE 2035 17.54(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.41% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Mars Petcare (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Merck Animal Health (US), VCA Inc. (US), PetSmart (US), Nestle Purina PetCare (US), Idexx Laboratories (US)
Segments Covered Service Type, Animal Type, Product Type, End User
Key Market Opportunities Integration of telemedicine and digital health solutions in the North America Veterinary Care Market.
Key Market Dynamics Rising demand for advanced veterinary services drives innovation and competition in the North America Veterinary Care Market.
Countries Covered US, Canada

Frequently Asked Questions

What is the projected market valuation of the North America Veterinary Care Market by 2035?

The North America Veterinary Care Market is projected to reach a valuation of 17.54 USD Billion by 2035.

What was the market valuation of the North America Veterinary Care Market in 2024?

In 2024, the market valuation of the North America Veterinary Care Market was 12.12 USD Billion.

What is the expected CAGR for the North America Veterinary Care Market during the forecast period 2025 - 2035?

The expected CAGR for the North America Veterinary Care Market during the forecast period 2025 - 2035 is 3.41%.

Which segment is projected to have the highest valuation in the North America Veterinary Care Market by 2035?

By 2035, the Diagnostic Services segment is projected to reach a valuation of 6.54 USD Billion.

What are the key players in the North America Veterinary Care Market?

Key players in the North America Veterinary Care Market include Mars Petcare, Zoetis, Boehringer Ingelheim, and Elanco Animal Health.

How much is the Companion Animals segment expected to grow by 2035?

The Companion Animals segment is expected to grow from 5.0 USD Billion in 2024 to 7.0 USD Billion by 2035.

What is the projected valuation for the Emergency Care segment by 2035?

The Emergency Care segment is projected to reach a valuation of 2.6 USD Billion by 2035.

What is the expected growth for the Pet Food segment in the North America Veterinary Care Market?

The Pet Food segment is expected to grow from 3.0 USD Billion in 2024 to 4.0 USD Billion by 2035.

Which end user segment is anticipated to see the most growth by 2035?

The Veterinary Clinics segment is anticipated to grow from 3.63 USD Billion in 2024 to 5.25 USD Billion by 2035.

What is the projected valuation for the Vaccines segment by 2035?

The Vaccines segment is projected to reach a valuation of 2.1 USD Billion by 2035.

Author
Author Author Profile Rahul Gotadki LinkedIn Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.